Jérôme de Sèze to Retrospective Studies
This is a "connection" page, showing publications Jérôme de Sèze has written about Retrospective Studies.
Connection Strength
0.081
-
Outcomes of coronavirus disease 2019 in patients with neuromyelitis optica and associated disorders. Eur J Neurol. 2021 Oct; 28(10):3461-3466.
Score: 0.023
-
Relapsing optic neuritis: a multicentre study of 62 patients. Mult Scler. 2014 06; 20(7):848-53.
Score: 0.014
-
Myelopathies secondary to Sjögren's syndrome: treatment with monthly intravenous cyclophosphamide associated with corticosteroids. J Rheumatol. 2006 Apr; 33(4):709-11.
Score: 0.008
-
DMTs and Covid-19 severity in MS: a pooled analysis from Italy and France. Ann Clin Transl Neurol. 2021 08; 8(8):1738-1744.
Score: 0.006
-
Clinical Characteristics and Outcomes in Patients With Coronavirus Disease 2019 and Multiple Sclerosis. JAMA Neurol. 2020 09 01; 77(9):1079-1088.
Score: 0.006
-
Brain MRI Findings in Severe COVID-19: A Retrospective Observational Study. Radiology. 2020 11; 297(2):E242-E251.
Score: 0.006
-
Multiple sclerosis with atypical MRI presentation: Results of a nationwide multicenter study in 57 consecutive cases. Mult Scler Relat Disord. 2019 Feb; 28:109-116.
Score: 0.005
-
Inaugural tumor-like multiple sclerosis: clinical presentation and medium-term outcome in 87 patients. J Neurol. 2018 Oct; 265(10):2251-2259.
Score: 0.005
-
Clinical spectrum and prognostic value of CNS MOG autoimmunity in adults: The MOGADOR study. Neurology. 2018 05 22; 90(21):e1858-e1869.
Score: 0.005
-
[Treatment of progressive multiple sclerosis with cyclophosphamide]. Rev Neurol (Paris). 2002 Jan; 158(1):65-9.
Score: 0.002
-
Long-term follow-up of neurosarcoidosis. Neurology. 2001 Sep 11; 57(5):927-9.
Score: 0.002